SCHEMBL9364264

SCHEMBL9364264

COc1cccc2c1ccc(=O)n2CCCN1CCN(c2cccc(C(F)(F)F)c2)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 5/20 0.53
KDM4E B2RXH2 1/20 0.53
ALOX15 P16050 1/20 0.53
TSHR P16473 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
HTR1A P08908 3/20 0.51
HTR2A P28223 2/20 0.51
ABCB11 O95342 1/20 0.51
ADRA2A P08913 1/20 0.51
ADORA3 P0DMS8 1/20 0.51
CHRM1 P11229 1/20 0.51
DRD1 P21728 1/20 0.51
TBXA2R P21731 1/20 0.51
SLC6A4 P31645 1/20 0.51
ADRA1A P35348 1/20 0.51
OPRM1 P35372 1/20 0.51
DRD3 P35462 1/20 0.51
KCNH2 Q12809 1/20 0.51
HTR2C P28335 1/20 0.51
HTR6 P50406 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9083376 0.99 HTR7 (0.52) HTR7KDM4EALOX15TSHRTDP1
SCHEMBL9364262 0.87 SIGMAR1 (0.58) HTR7HTR1AKCNH2MEN1USP2
SCHEMBL9364073 0.86 HTR1A (0.47) HTR7HTR1AHTR2ADRD3KCNH2
Hydrochloric Acid SCHEMBL9083564 0.81 DRD4 (0.51) HTR7HTR1ADRD3
Hydrochloric Acid SCHEMBL9083559 0.77 HTR7 (0.55) HTR7HTR1A
SCHEMBL11465528 0.77 SIGMAR1 (0.76) HTR7TSHRTDP1HTR1AHTR2A
SCHEMBL7557595 0.77 HTR1A (0.69) HTR7KDM4EALOX15TSHRTDP1
SCHEMBL7058125 0.76 HTR7 (0.58) HTR7HTR1AHTR2AABCB11ADRA2A
SCHEMBL8125860 0.75 HTR7 (0.62) HTR7HTR1AHTR2AABCB11ADRA2A
SCHEMBL9364308 0.75 SIGMAR1 (0.77) HTR7DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0512525-B1 Carbostyril derivatives and pharmaceutical compositions containing the same for use as a disturbance-of-consciousness improving agent, central nervous system stimulant or sigma receptor agonist OTSUKA PHARMA CO LTD (JP) 1994-11-30 EP claimed
US-20100009983-A1 5 HT RECEPTOR MEDIATED NEUROGENESIS BRAINCELLS, INC. (US) 2010-01-14 US disclosed
US-20100009983-A1 5 HT RECEPTOR MEDIATED NEUROGENESIS BRAINCELLS, INC. (US) 2010-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009983-A1 5 HT RECEPTOR MEDIATED NEUROGENESIS HTR6, GAP43, HTR5A HTR7 11/4885KDM4E 3933/4885ALOX15 944/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.